Lycobetaine acts as a selective topoisomerase IIβ poison and inhibits the growth of human tumour cells

50Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The phenanthridine alkaloid lycobetaine is a minor constituent of Amaryllidaceae. Inhibition of cell growth was studied in the clonogenic assay on 21 human tumour xenografts (mean IC 50 = 0.8 μM). The growth of human leukaemia cell lines was also potently inhibited (mean IC 50 = 1.3 μM). Athymic nude mice, carrying s.c. implanted human gastric tumour xenograft GXF251, were treated i.p. with lycobetaine for 4 weeks, resulting in a marked tumour growth delay. Lycobetaine was found to act as a specific topoisomerase IIβ poison, in the presence of calf thymus DNA, pure recombinant human topoisomerase IIβ protein was selectively depleted from SDS-gels, whereas no depletion of topoisomerase IIα protein was observed. In A431 cells immunoband-depletion of topoisomerase IIβ was induced, suggesting stabilization of the covalent catalytic DNA-intermediate in living cells. It is reasonable to assume that this mechanism will cause or at least contribute significantly to the antitumour activity. © 2001 Cancer Research Campaign.

Cite

CITATION STYLE

APA

Barthelmes, H. U., Niederberger, E., Roth, T., Schulte, K., Tang, W. C., Boege, F., … Marko, D. (2001). Lycobetaine acts as a selective topoisomerase IIβ poison and inhibits the growth of human tumour cells. British Journal of Cancer, 85(10), 1585–1591. https://doi.org/10.1054/bjoc.2001.2142

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free